PREDICTIVE CIRCULATING MARKERS FOR ANTHRACYCLINE CHEMOTHERAPY IN NON-METASTATIC BREAST CANCER

Anthracyclines are used in breast cancer both in early and advanced stages and their recommendation together with taxanes, either concurrently or sequentially, is debatable and individualized by phenotype. Circulating biomarkers have already been introduced in clinical practice for metastatic diseas...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Acta Endocrinol (Buchar)
Hlavní autoři: Botnariuc, I., Ilie, S.M., Trifanescu, O.G., Bacinschi, X.E., Curea, F., Anghel, R.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Acta Endocrinologica Foundation 2017
Témata:
Review / Extensive Clinical Experience
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516453/
https://ncbi.nlm.nih.gov/pubmed/31149175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4183/aeb.2017.209
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky